Human vaccines and immunotherapeutics: News October 2024
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2429976 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849738185962160128 |
|---|---|
| author | Ronald Ellis Adam Weiss |
| author_facet | Ronald Ellis Adam Weiss |
| author_sort | Ronald Ellis |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9f8b4e0d7cfb45aaa825106ea2d32afa |
| institution | DOAJ |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-9f8b4e0d7cfb45aaa825106ea2d32afa2025-08-20T03:06:42ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2429976Human vaccines and immunotherapeutics: News October 2024Ronald Ellis0Adam Weiss1Jerusalem, IsraelTaylor & Francis Grouphttps://www.tandfonline.com/doi/10.1080/21645515.2024.2429976 |
| spellingShingle | Ronald Ellis Adam Weiss Human vaccines and immunotherapeutics: News October 2024 Human Vaccines & Immunotherapeutics |
| title | Human vaccines and immunotherapeutics: News October 2024 |
| title_full | Human vaccines and immunotherapeutics: News October 2024 |
| title_fullStr | Human vaccines and immunotherapeutics: News October 2024 |
| title_full_unstemmed | Human vaccines and immunotherapeutics: News October 2024 |
| title_short | Human vaccines and immunotherapeutics: News October 2024 |
| title_sort | human vaccines and immunotherapeutics news october 2024 |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2429976 |
| work_keys_str_mv | AT ronaldellis humanvaccinesandimmunotherapeuticsnewsoctober2024 AT adamweiss humanvaccinesandimmunotherapeuticsnewsoctober2024 |